Since the company registration twenty-three events have happened. The last three records are Statement of capital following an allotment of shares on 15 March 2017 GBP 17.5958 ; Resolutions RES11 ‐ Resolution of removal of pre-emption rights ; Registered office address changed from Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ England to Future Space Uwe North Gate, Filton Road Stoke Gifford Bristol BS34 8QZ on 16 November 2016. The most likely internet sites of PERTINAX PHARMA LIMITED are www.pertinaxpharma.co.uk, and www.pertinax-pharma.co.uk. The predicted number of employees is 1 to 10. The company’s age is ten years and ten months. The distance to to Bristol Parkway Rail Station is 1.1 miles; to Bristol Temple Meads Rail Station is 3.7 miles; to Avonmouth Rail Station is 6.4 miles; to Chepstow Rail Station is 11 miles is 2.7 miles. This is straight distance. Please bear in mind the walking distance could be longer.Pertinax Pharma Limited is a Private Limited Company. The company registration number is 09557364. Pertinax Pharma Limited has been working since 23 April 2015. The present status of the company is Active. The registered address of Pertinax Pharma Limited is Future Space Uwe North Gate Filton Road Stoke Gifford Bristol England Bs34 8rb. . COOPER, Ashley Stephen Charles is a Director of the company. DARBY, Rosalind May is a Director of the company. GIBSON, Stuart James is a Director of the company. REDMOND, Michele Emily, Dr is a Director of the company. MERCIA FUND MANAGEMENT (NOMINEES) LIMITED is a Director of the company. Director ALEXANDROFF, James Michael has been resigned. Director SUNDSTROM, Susan Margaret has been resigned. The company operates in "Research and experimental development on biotechnology".